Listen to the interview here: Aaron Hansen, MD, shares key findings from the theraPb trial in mCRPC | Urology Times
AdvanCell is a radiopharmaceutical company that is developing a revolutionary cancer treatment called Targeted Alpha Therapy, providing new hope for patients with untreatable cancers.
